HDAC-IN-31 - CAS 1916505-13-9

HDAC-IN-31 is a selective, potent, orally active HDAC inhibitor that acts on HDAC1 (IC50: 84.90 nM), HDAC2 (IC50: 168.0 nM), HDAC3 (IC50: 442.7 nM), HDAC8 (IC50>10000 nM) . HDAC-IN-31 has good anti-tumour effects. HDAC-IN-31 has shown potential research value in diffuse large B-cell lymphoma.

Apoptosis, Others, HDAC

Chromatin/Epigenetic, DNA Damage/DNA Repair, Apoptosis, Others

1916483

C25H24N4O2

412.48

C(N1C(=O)\C(=C\C2=CC=CC=N2)\CCC1)C3=CC=C(C(NC4=C(N)C=CC=C4)=O)C=C3

-20°C

Ice Packs

Small Compound